Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Antonia Centra"'
Autor:
Antonia Centra, Pasquale Niscola, Massimo Breccia, Luana Fianchi, Elena Maria Elli, Barbara Anaclerico, Roberto Latagliata, Roberto Foa, Ida Carmosino, Andrea Aroldi, Ambra Di Veroli, Nicoletta Villivà, Alessandro Andriani, Vincenza Martini, Guido Montanaro, Giulio Trapè, Maria Teresa Voso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d86e81f7eec0019e78cef2333032f245
https://doi.org/10.1002/hon.2635/v2/response1
https://doi.org/10.1002/hon.2635/v2/response1
Autor:
Pasquale Niscola, Giulio Trapè, Luana Fianchi, Antonia Centra, Roberto Latagliata, Ambra Di Veroli, Elena Maria Elli, Andrea Aroldi, Marco Montanaro, Guido Montanaro, Vincenza Martini, Barbara Anaclerico, Nicoletta Villivà, Ida Carmosino, Alessandro Andriani, Roberto Foa, Massimo Breccia, Maria Teresa Voso
There have been some reports on a possible role of azacytidine (AZA) in the treatment of accelerated/blastic phase evolved from Philadelphia-negative myeloproliferative neoplasms (MPN-AP/BP), but results are conflicting. In this study, we analyzed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c02be63e2bcd12fb9a089098afd4b3
http://hdl.handle.net/10281/278730
http://hdl.handle.net/10281/278730
Autor:
Marco Montanaro, Luca Maurillo, Ambra Di Veroli, Barbara Anaclerico, Roberto Ricci, Elena Rossi, Atelda Romano, Luca Petriccione, Valerio De Stefano, Roberto Latagliata, Annamaria Rauco, Giuliana Alimena, Nicoletta Villivà, Elisabetta Abruzzese, Ada D'Addosio, Massimo Breccia, Alessandro Andriani, Cristina Santoro, Cinzia De Gregoris, Malgorzata Monika Trawinska, Antonia Centra, Sabrina Crescenzi Leonetti, Marianna De Muro
Background Thrombotic episodes are the major complication in the follow-up of Philadelphia negative Myeloproliferative Neoplasms (MPN), with high morbidity and mortality, as reported in several retrospective studies. At present, however, few prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc106d28d36bc748ccccb03844e99e9
http://hdl.handle.net/11573/987310
http://hdl.handle.net/11573/987310
Autor:
Adalberto Ibatici, Francesca Palandri, Massimiliano Bonifacio, Bruno Martino, Barbara Anaclerico, Margherita Perricone, Costanza Bosi, Mariella D'Adda, Luca Petriccione, Monica Crugnola, Michele Cavo, Giulia Benevolo, Micaela Bergamaschi, Nicola Polverelli, Ambra Di Veroli, Mario Tiribelli, Giuseppe A. Palumbo, Massimo Breccia, Nicola Vianelli, Alessia Tieghi, Alessandro Andriani, Malgorzata Monika Trawinska, Marco Montanaro, Roberto Latagliata, Francesco Cavazzini, Antonia Centra
Publikováno v:
Università degli Studi di Verona-IRIS
Background. Ruxolitinib (RUX) is the first commercially available JAK1/2 inhibitor that may control splenomegaly and systemic symptoms related to myelofibrosis (MF). Despite MF occur frequently in elderly patients (pts), no data are yet available on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87399d31faa48d0083487ccab4213884
http://hdl.handle.net/11392/2372169
http://hdl.handle.net/11392/2372169
Autor:
Anna Candoni, Giuliana Alimena, Adriano Venditti, Eliana Zuffa, Marco Sborgia, Roberto Latagliata, Francesco Fabbiano, Massimo Breccia, Marco Vignetti, Francesco Di Raimondo, Franca Falzetti, Daniela Cilloni, Giovanni Martinelli, Francesco Lauria, Enrico Mattei, Simona Iacobelli, Antonio Peta, Domenico Pastore, Paola Fazi, Antonia Centra, Franco Mandelli, Monica Morselli, Monica Crugnola, Francesca Adamo
Publikováno v:
Blood. 108:1979-1979
The GSI 103 AMLE was a randomized phase III clinical trial to explore the efficacy of DaunoXome (DNX) versus Daunorubicin (DNR) standard treatment in AML elderly patients. From 10/2001 to 2/2004, 301 patients aged 61 to 75 years with a diagnosis of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ccbb22020abd00c515fe7fdb54204c6
https://doi.org/10.1182/blood.v108.11.1979.1979
https://doi.org/10.1182/blood.v108.11.1979.1979
Autor:
Antonia Centra, G. Gamba, M. Mattioli Belmonte, M. G. Mazzucconi, G. Specchia, Andrea Camera, Giuseppe Leone, V. De Stefano, F. Dragoni, L. Gugliotta, F. Mandelli
Publikováno v:
Scopus-Elsevier
SummaryBlood coagulation abnormalities induced by administration of E. coli L-asparaginase were investigated in 25 patients with acute lymphoblastic leukemia treated according to the GIMEMA ALL 0288 trial. Dosage of L-asparaginase was relatively low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701141d840e025d9d9bef9c948297bdb
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027469269&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027469269&partnerID=MN8TOARS